manufacturers of glp-1 drugs trend to impact food Comparing Ozempic, Wegovy and Other
Description
Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia
Most users must continue medication indefinitely to sustain therapeutic benefits
Clinical wins, safety setbacks, generics pressure, and aggressive IP maneuvering are reshaping the competitive landscape at record speed
doi: 10.1038/304368a0 14 HansenLDeaconCFOrskovCHolstJJ
Every body is different
US National Libary of Medicine
